Mounjaro – Ayaksız

Eli Lilly’s Q2 Earnings Surpass Expectations, Raises Full-Year Outlook

Eli Lilly reported stellar second-quarter earnings, significantly exceeding market expectations, driven by robust sales of its diabetes drug Mounjaro and weight loss injection Zepbound. The pharmaceutical...

Science 3 ay ago

Eli Lilly’s Zepbound and Mounjaro Now Available in U.S. After Shortages, FDA Says

ayaksız

All doses of Eli Lilly’s highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the U.S., according to the latest update...

Etiket: Mounjaro

Eli Lilly’s Q2 Earnings Surpass Expectations, Raises Full-Year Outlook

Eli Lilly’s Zepbound and Mounjaro Now Available in U.S. After Shortages, FDA Says

Ayaksız / www.ayaksiz.net

Newsletter